COCP — Cocrystal Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- $14.75m
- -$11.60m
- 15
- 47
- 34
- 23
Annual cashflow statement for Cocrystal Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -48.2 | -9.65 | -14.2 | -38.8 | -18 |
| Depreciation | |||||
| Non-Cash Items | 46.2 | 0.718 | 0.672 | 19.9 | 0.787 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.287 | -1.06 | 0.604 | -2.71 | 2.34 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -1.56 | -9.83 | -12.7 | -21.4 | -14.7 |
| Capital Expenditures | -0.145 | -0.24 | -0.052 | -0.074 | -0.118 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.145 | -0.24 | -0.052 | -0.074 | -0.118 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 6.42 | 35.7 | 38.5 | -0.027 | 3.99 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 4.72 | 25.6 | 25.7 | -21.5 | -10.8 |